Literature DB >> 1374812

Altered cell tropism and cytopathicity of feline immunodeficiency viruses in two different feline CD4-positive, CD8-negative cell lines.

K Tokunaga1, Y Nishino, H Oikawa, C Ishihara, T Mikami, K Ikuta.   

Abstract

Two interleukin-2-dependent feline CD4-positive and CD8-negative cell lines, MYA-1 and the newly established FeL-039, were used as host cells for infection with feline immunodeficiency virus (FIV). All FIV strains used, the Petaluma strain and several new isolates, were highly cytopathic to MYA-1. In contrast, the kinetics of FIV replication in FeL-039 differed greatly depending on the strain tested, i.e., noninfectious strain, highly cytopathic strain, and less cytopathic strain producing a persistent state for a long period. It appears, therefore, that cell tropism for FIV differed with each FIV strain tested even in T-cell lines showing similar cell surface phenotypes. Cytopathicity of FIV is evidently due to both the FIV strain and the host T cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374812      PMCID: PMC241177     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors.

Authors:  S Morikawa; T F Booth; D H Bishop
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

2.  Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone.

Authors:  K A Clouse; D Powell; I Washington; G Poli; K Strebel; W Farrar; P Barstad; J Kovacs; A S Fauci; T M Folks
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

3.  Replication of cat leukemia virus in cell suspension cultures.

Authors:  G H Theilen; T G Kawakami; J D Rush; R J Munn
Journal:  Nature       Date:  1969-05-10       Impact factor: 49.962

4.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

5.  Immunoassay for detection of feline immunodeficiency virus core antigen.

Authors:  G K Tilton; T P O'Connor; C L Seymour; K L Lawrence; N D Cohen; P R Andersen; Q J Tonelli
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes.

Authors:  W C Brown; L Bissey; K S Logan; N C Pedersen; J H Elder; E W Collisson
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Nucleotide sequence and genomic organization of feline immunodeficiency virus.

Authors:  R L Talbott; E E Sparger; K M Lovelace; W M Fitch; N C Pedersen; P A Luciw; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

9.  Preliminary comparisons of the biological properties of two strains of feline immunodeficiency virus (FIV) isolated in Japan with FIV Petaluma strain isolated in the United States.

Authors:  T Miyazawa; T Furuya; S Itagaki; Y Tohya; K Nakano; E Takahashi; T Mikami
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

View more
  6 in total

1.  The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes.

Authors:  K Tomonaga; T Miyazawa; J Sakuragi; T Mori; A Adachi; T Mikami
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

2.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

3.  The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus.

Authors:  E Mortola; Y Endo; K Ohno; T Watari; H Tsujimoto; A Hasegawa
Journal:  Vet Res Commun       Date:  1998-12       Impact factor: 2.459

Review 4.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Feline CD4 molecules expressed on feline non-lymphoid cell lines are not enough for productive infection of highly lymphotropic feline immunodeficiency virus isolates.

Authors:  J Norimine; T Miyazawa; Y Kawaguchi; K Tomonaga; Y S Shin; T Toyosaki; M Kohmoto; M Niikura; Y Tohya; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; M Kohmoto; Y Inoshima; K Maeda; T Mikami; K ] Maedadel K [corrected to Maeda
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.